Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Fitstry vs HealthSource

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #242
Fitstry

Fitstry is the GLP-1 weight-loss program of Weightstry, LLC, a LegitScript-certified, cash-pay telehealth practice focused on women 40+.

Marked down on: Month-to-month pricing is notably higher than the annual plan ($249 vs $179 semaglutide, $339 vs $269 tirzepatide)

vs
Dispatch #31Desk pick
HealthSource

HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.

Marked down on: No physician names or clinical leadership disclosed on public pages

HealthSource takes this head-to-head with the higher Desk Score, 84/100 (B) against 64/100 (C) for Fitstry. Fitstry still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Fitstry

64/100

C

Overall

HealthSource

84/100

B

Price transparency

68
94

State access

24
86

Molecule range

77
77

Onboarding speed

66
79

Support responsiveness

89
85

Licensing & trust

76
69

The spec sheet

FieldFitstryHealthSource
Semaglutide$179/mo (annual plan, plus a separate fee, compounded)$199/mo (all doses, compounded)
Tirzepatide$269/mo (annual plan, compounded)$299/mo (all doses, compounded)
CoverageCoverage not publishedAll 50 states
Brand-nameCompounded onlyCompounded only
Oral optionYesYes
Best forReaders who want transparent compounded semaglutide, tirzepatide or oral GLP-1 for women 40+ with a refundable $99 intake.Readers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.
Desk Score64/100C84/100B

The verdict

Desk pick — HealthSource

HealthSource takes this head-to-head with the higher Desk Score, 84/100 (B) against 64/100 (C) for Fitstry. Fitstry still holds its ground where its strengths line up with yours.

Choose Fitstry if…

Readers who want transparent compounded semaglutide, tirzepatide or oral GLP-1 for women 40+ with a refundable $99 intake.

$179/mo (annual plan, plus a separate fee, compounded) sema · $269/mo (annual plan, compounded) tirz · Coverage not published

Choose HealthSource if…

Readers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.

$199/mo (all doses, compounded) sema · $299/mo (all doses, compounded) tirz · All 50 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Fitstry · HealthSource.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.